BML Investment Partners, L.P. 13D and 13G filings for Achilles Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 5:02 pm Unchanged |
2024-12-31 | 13G | Achilles Therapeutics plc ACHL |
BML Investment Partners, L.P. | 4,100,002 9.970% |
0 (Unchanged) |
Filing |
| 2024-09-25 7:14 pm Purchase |
2024-09-19 | 13G | Achilles Therapeutics plc ACHL |
BML Investment Partners, L.P. | 4,100,002 9.970% |
4,100,002 (New Position) |
Filing |